Here's What a $5,000 Investment in Broadcom Could Be Worth by 2032

Broadcom’s AI chip sales rose 65% to $20 billion, or 31% of fiscal 2025 revenue, and the company expects them to reach $115 billion by fiscal 2027. Analysts expect revenue and adjusted EBITDA to grow at CAGRs of 62% and 63%, respectively, from fiscal 2025 to fiscal 2028. The article presents a nearly tenfold stock gain by 2032 as a best-case scenario based on continued growth and a higher valuation multiple, while noting the shares could still double or triple if growth cools.

Analysis

The market is increasingly valuing AVGO as an AI infrastructure compounder, but the key underwriting question is whether custom silicon converts into durable, repeatable economics—not simply whether hyperscaler capex stays high. ASIC adoption can pressure NVIDIA’s accelerator share at the margin while expanding demand for Ethernet and optical connectivity; it is not necessarily a zero-sum GPU replacement, since customers may deploy mixed architectures and retain GPUs for flexible workloads. The second-order risk is customer bargaining power: a small number of large buyers can redirect designs, negotiate pricing, or develop more silicon in-house. Verify customer concentration, committed volumes, and production capacity before treating projected AI revenue as bankable.

Near term, sentiment and positioning leave AVGO vulnerable to any guidance miss or delay in customer ramps. Over 1–3 months, reported AI revenue, order visibility, and gross-margin trajectory matter more than broad AI-market forecasts. Over 6–18 months, software execution could provide some earnings ballast, but its slower growth means the equity multiple may remain increasingly dependent on semiconductor delivery. The article’s extreme 2032 scenario is not a useful base case: it relies on sustained exceptional growth and substantial multiple expansion, while the implied market-cap outcome highlights how much optimism is embedded in the endpoint.

Contrarian angle: investors may overstate direct substitution of NVIDIA GPUs, but also underappreciate AVGO’s networking/interconnect attach opportunity. The thesis weakens if AI sales growth decelerates materially, customer programs slip, or margins disappoint despite revenue growth.

Key Decisions for Investors

• Prefer staged AVGO exposure over chasing a sharp AI-led rally: add only on confirmation from reported AI revenue, backlog/order commentary, and margins. Reassess if management signals program delays or if AI growth decelerates while semiconductor margins contract.
• Consider a small, risk-defined relative-value position—long AVGO versus short NVDA—only for investors explicitly underwriting custom-ASIC share gains. Keep the hedge modest: GPU and ASIC demand can both rise with capex, and NVDA’s broader platform makes this a risky substitution trade.
• Track hyperscaler capex and silicon sourcing at Alphabet and Meta, plus AVGO customer concentration, production capacity, and the portion of AI revenue tied to repeat deployments. Treat the large forward revenue projection as unverified until supported by company guidance and realized shipments.
• Do not underwrite the extreme long-dated return case as a base scenario. Falsifiers include customer insourcing or design changes, delayed ramps, weaker networking attach, falling AI-related margins, or a valuation that contracts as growth normalizes.